Jae-Kyung Lim

Title: Jae-Kyung Lim: Innovator in Antibacterial Research

Introduction

Jae-Kyung Lim is a notable inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of antibacterial research, particularly through his innovative work on quinolone carboxylic acid derivatives. With a total of 2 patents, Lim continues to push the boundaries of pharmaceutical science.

Latest Patents

One of Lim's latest patents focuses on quinolone carboxylic acid derivatives. This invention relates to compounds that exhibit superior antibacterial activities compared to existing quinolone-series antibiotics. Specifically, it pertains to novel quinolone carboxylic acid derivatives represented by a specific formula, which includes a derivative of 7-[8-(alkoxyimino)-2,6-diazaspiro[3.4]oct-6-yl] as a substituent, along with pharmaceutically acceptable salts and isomers thereof.

Career Highlights

Jae-Kyung Lim is currently associated with Dong Wha Pharmaceutical Industrial Co., Ltd. His work has been instrumental in developing new antibacterial agents that can potentially address the growing issue of antibiotic resistance. Lim's research is characterized by a commitment to enhancing the efficacy of existing treatments.

Collaborations

Throughout his career, Lim has collaborated with several esteemed colleagues, including Yong-ho Chung and Sung-Joon Yoon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Jae-Kyung Lim's contributions to antibacterial research through his innovative patents highlight his role as a leading inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also has the potential to improve public health outcomes.